Abraxane - supply shortage
Resolved
paclitaxel
ShortageHuman
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Shortage information
The shortage affecting Abraxane has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Abraxane
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- paclitaxel
- Therapeutic area (MESH)
- Breast Neoplasms
- Pancreatic Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Pharmaceutical forms affected
- Powder for dispersion for injection
- Strengths affected
- 5 mg/ml
- Availability of alternatives
- Yes
Key dates
- First published
- Last updated